Advanced Biomed (NASDAQ:ADVB) Stock Price Down 10% – Here’s Why

Advanced Biomed Inc. (NASDAQ:ADVB) fell 10% during mid-day trading on Friday . The company traded as low as $4.49 and last traded at $4.49. Approximately 3,896 shares were traded during trading, a decline of 90% from the average daily volume of 38,493 shares. The stock had previously closed at $4.99.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Advanced Biomed has a consensus rating of “Sell”.

Advanced Biomed Price Performance

The company has a market capitalization of $7.41 million, a price-to-earnings ratio of 0.93 and a beta of 0.68. The business has a fifty day simple moving average of $4.83.

Advanced Biomed (NASDAQ:ADVB) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.38) earnings per share for the quarter.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.